• Nie Znaleziono Wyników

Interrupted aorta in mosaic Turner syndrome

N/A
N/A
Protected

Academic year: 2022

Share "Interrupted aorta in mosaic Turner syndrome"

Copied!
2
0
0

Pełen tekst

(1)

IMAGES IN CARDIOLOGY

Cardiology Journal 2011, Vol. 18, No. 5, pp. 568–569 10.5603/CJ.2011.0016 Copyright © 2011 Via Medica ISSN 1897–5593

568 www.cardiologyjournal.org

Address for correspondence: Dr. Vikrant Nayar, MBChB MRCP, Department of Cardiology, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0QQ, United Kingdom, tel: +441223349148, fax: +441223349149, e-mail: vikrantnayar@nhs.net Received: 12.11.2010 Accepted: 10.01.2011

Interrupted aorta in mosaic Turner syndrome

Vikrant Nayar, Anna Santarsieri, Mark Belham

Department of Cardiology, Addenbrooke’s Hospital, Cambridge, United Kingdom

A 28 year-old female with a four year history of primary infertility, oligomenorrhoea and menor- rhagia presented to the sub-fertility clinic at our institution for further investigations. Her short sta- ture (141 cm) and obesity (73 kg; body mass index 36.7 kg/m2) prompted karyotype testing which con- firmed mosaic Turner syndrome.

Otherwise, she had had poorly controlled hyper- tension for many years and was currently being pre- scribed labetalol for presumed primary hypertension.

Her blood pressure remained elevated at 158/

/104 mm Hg, but attempts to add other antihyperten- sive medications had not been tolerated due to trou- blesome side effects. Echocardiography had previous- ly shown a bicuspid aortic valve, but no left ventricu- lar hypertrophy or other structural abnormality.

Due to concerns about potential secondary causes for hypertension, she proceeded to magnetic resonance imaging of her aorta. This indeed de- monstrated a post-ductal interrupted aorta (Fig. 1) with extensive collateralization and enlargement of the internal mammary arteries (Fig. 2). Currently, she is awaiting surgical repair of the interrupted aorta with fertility treatment postponed until after surgery.

Cardiovascular disease is the commonest cause of death in Turner syndrome, with life expectancy reduced by approximately ten years [1, 2]. Aortic valve disease (particularly bicuspid valve morpho- logy) and aortic coarctation are the commonest car- diovascular anomalies. Aortic root dilatation, aor- tic dissection, hypertension, mitral valve prolapse,

Figure 2. Magnetic resonance angiography showing extensive intercostal collateralization and enlargement of the internal mammary arteries.

Figure 1. Magnetic resonance imaging showing a com- plete interruption of the descending aorta.

(2)

569 Vikrant Nayar et al., Interrupted aorta in mosaic Turner syndrome

www.cardiologyjournal.org

partial anomalous venous drainage and ischemic heart disease are also encountered more com- monly than in the general population. However, the prevalance of cardiac anomalies differs con- siderably between females with X chromosome monosomy (45X) and those with mosaicism (45X/

/46XX) [3].

The prevalence of cardiovascular malforma- tions is about 38% in monosomy and 11% in mosai- cism. Aortic valve disease and coarctation occur at frequencies of 28% and 17% in monosomy, com- pared to 7% and 2% in mosaicism, respectively.

Complete aortic interruption, rather than coarcta- tion, has rarely been described in Turner syndrome [4] and we believe this is the first reported case in a mosaic patient.

Acknowledgements

The authors do not report any conflict of inte- rest regarding this work.

References

1. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner’s syn- drome in adulthood. Endocr Rev, 2002; 23: 120–140.

2. Price WH, Clayton JF, Collyer S, De Mey R, Wilson J. Mortality ratios, life expectancy, and causes of death in patients with Turner’s syndrome. J Epidemiol Community Health, 1986; 40: 97–102.

3. Gøtzsche CO, Krag-Olsen B, Nielsen J, Sørensen KE, Kristensen BO.

Prevalence of cardiovascular malformations and association with karyotypes in Turner’s syndrome. Arch Dis Child, 1994; 71:

433–436.

4. Mutlu M, Dilber E, Aslan Y, Okten A, Oztürk O. A Turner syn- drome case associated with anal atresia, interrupted aortic arch and multicystic dysplastic kidney. Turk J Pediatr, 2010; 52: 215–217.

Cytaty

Powiązane dokumenty

1) Sustained hemodynamic changes are observed as peak velocity and transvalvular gradient dif- ferences between discharge and follow-up within 1 year after the procedure; 2) BAV

Transfemoral implantation of a covered metal stent across the fracture site and successful restoration of the aortic trajectory, without signs of residual dissection;

Heart defects most commonly include septal defects, followed by aortic coarctation (CoA), mitral valve defects, pat- ent ductus arteriosus (PDA), and conduction disturbances

ence of >48° angle between the aortic annulus Transcatheter aortic valve implantation (TAVI)4. is a well ‑established modern treatment of severe symptomatic

1 2 nd Department of Medicine, Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic..

CarnaLife Holo ® (MedApp S.A., Krakow, Poland) visualises the individual patient’s heart as an interactive holographic image based on computed tomography (CT) or a

In cohort B of the PARTNER 1 study, which included patients who were not deemed candidates for SAVR due to extremely (prohibitive) high surgical risk, medical treatment was

Our study confirmed that type I bicuspid aortic valve (fusion of the right and left-coronary cusp) is associated with increased diameter of aorta, especially at the level of